The Natural Compound CalebinA Suppresses Gemcitabine Resistance and Tumor Progression by Inhibiting Angiogenesis and Invasion Through NF-κB Signaling in Pancreatic Cancer
Nutrients · 2025
DOI: 10.3390/nu17162641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Yuki Eguchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Deoxycytidine, Drug Resistance, Neoplasm, NF-kappa B. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Previously, we established gemcitabine (Gem)-resistant pancreatic cancer (PaCa) cell lines and showed that the acquisition of Gem resistance is accompanied by enhanced activation of the inflammatory transcription factor nuclear factor-κB (NF-κB). In this study, we focus on CalebinA, a natural compound derived from the rhizomes of turmeric, known for its potent anti-inflammatory properties. It has been suggested that this compound may exert anticancer effects by downregulating the NF-κB signaling cascade. Therefore, we collaborated with Sabinsa Corporation, Japan, to explore its potential application in pancreatic cancer therapy.
Methods
We used gemcitabine-resistant pancreatic cell lines to demonstrate the effect of CalebinA on cell toxicity, invasiveness, cytokine levels, NF-κB p65 activity, and tube formation in angiogenesis. Tumor volume and histopathological analysis were used to analyze the effects of CalebinA on tumors induced by the subcutaneous injection of pancreatic cell lines in mice.
Results
Treatment with 10 μM CalebinA significantly inhibited NF-κB activity. Gem-resistant PaCa cells exhibited higher invasive and angiogenic capacities than non-resistant parental cells; however, these capacities were markedly suppressed by CalebinA. In vivo, intraperitoneal CalebinA administration every 3 days led to a significant reduction in tumor volume in mice bearing subcutaneous xenografts of the AsPC-1 pancreatic cancer cell line. Immunohistochemical analysis revealed that CalebinA suppressed the expression of Ki-67, CD31-positive microvessel density, and NF-κB p65.
Conclusions
These findings suggest that CalebinA holds promise as a novel therapeutic agent for Gem-resistant pancreatic cancer and may be a strong candidate for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
- Department of Gastroenterological Surgery, East Medical Center, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.
ORCID-Profile: Yoichi Matsuo, Ryo Ogawa
Zitieren
APA
Eguchi, Y., Matsuo, Y., Ishida, M., Uehara, Y., Sugita, S., Denda, Y., Nonoyama, K., Murase, H., Kato, T., Saito, K., Sato, T., Sagawa, H., Yamakawa, Y., Ogawa, R., Takahashi, H., Mitsui, A., & Takiguchi, S. (2025). The Natural Compound CalebinA Suppresses Gemcitabine Resistance and Tumor Progression by Inhibiting Angiogenesis and Invasion Through NF-κB Signaling in Pancreatic Cancer. Nutrients. https://doi.org/10.3390/nu17162641
Vancouver
Eguchi Y, Matsuo Y, Ishida M, Uehara Y, Sugita S, Denda Y, et al. The Natural Compound CalebinA Suppresses Gemcitabine Resistance and Tumor Progression by Inhibiting Angiogenesis and Invasion Through NF-κB Signaling in Pancreatic Cancer. Nutrients. 2025. doi:10.3390/nu17162641
BibTeX
@article{Eguchi2025,
author = {Eguchi, Yuki and Matsuo, Yoichi and Ishida, Masaki and Uehara, Yuriko and Sugita, Saburo and Denda, Yuki and Nonoyama, Keisuke and Murase, Hiromichi and Kato, Tomokatsu and Saito, Kenta and Sato, Takafumi and Sagawa, Hiroyuki and Yamakawa, Yushi and Ogawa, Ryo and Takahashi, Hiroki and Mitsui, Akira and Takiguchi, Shuji},
title = {The Natural Compound CalebinA Suppresses Gemcitabine Resistance and Tumor Progression by Inhibiting Angiogenesis and Invasion Through NF-κB Signaling in Pancreatic Cancer},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17162641}
}
EUVIMED